Breaking News

WuXi STA, Coherent Biopharma Enter Strategic PDC Pact

WuXi STA to provide peptide platform services from drug discovery to commercial manufacturing to support Coherent’s PDC drug candidate development.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WuXi STA, a subsidiary of WuXi AppTec, and Coherent Biopharma, signed a strategic partnership agreement, under which, WuXi STA will become Coherent’s preferred CDMO partner to provide integrated CMC services to accelerate its present and future drug candidates (small molecule, peptide, oligonucleotide and complex chemical conjugate, etc.), from API to drug product, including process development, manufacturing, analytical and regulatory filing support.   Coherent Biopharma is dedicated to R&amp...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters